Sophie V. Vandebroek
CIK: 0001442078
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- May 12, 2026IDXX
IDEXX LABORATORIES INC /DE
Award(A)DirectNon-Qualified Stock Option (right-to-buy)
525 shares- - May 12, 2026IDXX
IDEXX LABORATORIES INC /DE
Award(A)DirectRestricted Stock Unit
234 shares- - May 7, 2026IDXX
IDEXX LABORATORIES INC /DE
Exercise(M)Direct257 shares- - May 7, 2026RVTY
REVVITY, INC.
Award(A)Direct1K shares- - May 7, 2026RVTY
REVVITY, INC.
Award(A)Direct1.3K shares- - Feb 17, 2026IDXX
IDEXX LABORATORIES INC /DE
Exercise(M)Direct945 shares at avg. $333.90$316K - Feb 17, 2026IDXX
IDEXX LABORATORIES INC /DE
Sale(S)Direct945 shares at avg. $628.65$594K - Feb 17, 2026IDXX
IDEXX LABORATORIES INC /DE
Sale(S)Direct519 shares at avg. $628.56$326K - May 9, 2025IDXX
IDEXX LABORATORIES INC /DE
Sale(S)Direct1.3K shares at avg. $491.34$628K - May 9, 2025IDXX
IDEXX LABORATORIES INC /DE
Exercise(M)Direct1.3K shares at avg. $283.59$363K - May 7, 2025IDXX
IDEXX LABORATORIES INC /DE
Award(A)DirectNon-Qualified Stock Option (right-to-buy)
600 shares- - May 7, 2025IDXX
IDEXX LABORATORIES INC /DE
Award(A)DirectRestricted Stock Unit
257 shares- - May 6, 2025IDXX
IDEXX LABORATORIES INC /DE
Exercise(M)Direct262 shares- - Apr 30, 2025RVTY
REVVITY, INC.
Award(A)Direct1.1K shares- - Apr 30, 2025RVTY
REVVITY, INC.
Award(A)Direct1.3K shares- - Nov 27, 2024IDXX
IDEXX LABORATORIES INC /DE
Sale(S)Direct344 shares at avg. $420.44$145K - Nov 27, 2024IDXX
IDEXX LABORATORIES INC /DE
Gift(G)Direct224 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 12, 2026 |  IDXX IDEXX LABORATORIES INC /DE | Award(A) Non-Qualified Stock Option (right-to-buy) | 525 | - | - | Direct |
| May 12, 2026 | IDXX IDEXX LABORATORIES INC /DE | Award(A) Restricted Stock Unit | 234 | - | - | Direct |
| May 7, 2026 | IDXX IDEXX LABORATORIES INC /DE | Exercise(M) | 257 | - | $0 | Direct |
| May 7, 2026 |  RVTY REVVITY, INC. | Award(A) | 1,015 | - | $0 | Direct |
| May 7, 2026 | RVTY REVVITY, INC. | Award(A) | 1,265 | - | $0 | Direct |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | Exercise(M) | 945 | $333.90 | $315,536 | Direct |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | Sale(S) | 945 | $628.65 | $594,070 | Direct |
| Feb 17, 2026 | IDXX IDEXX LABORATORIES INC /DE | Sale(S) | 519 | $628.56 | $326,223 | Direct |
| May 9, 2025 | IDXX IDEXX LABORATORIES INC /DE | Sale(S) | 1,279 | $491.34 | $628,425 | Direct |
| May 9, 2025 | IDXX IDEXX LABORATORIES INC /DE | Exercise(M) | 1,279 | $283.59 | $362,712 | Direct |
| May 7, 2025 | IDXX IDEXX LABORATORIES INC /DE | Award(A) Non-Qualified Stock Option (right-to-buy) | 600 | - | - | Direct |
| May 7, 2025 | IDXX IDEXX LABORATORIES INC /DE | Award(A) Restricted Stock Unit | 257 | - | - | Direct |
| May 6, 2025 | IDXX IDEXX LABORATORIES INC /DE | Exercise(M) | 262 | - | - | Direct |
| Apr 30, 2025 | RVTY REVVITY, INC. | Award(A) | 1,074 | - | - | Direct |
| Apr 30, 2025 | RVTY REVVITY, INC. | Award(A) | 1,338 | - | - | Direct |
| Nov 27, 2024 | IDXX IDEXX LABORATORIES INC /DE | Sale(S) | 344 | $420.44 | $144,630 | Direct |
| Nov 27, 2024 | IDXX IDEXX LABORATORIES INC /DE | Gift(G) | 224 | - | $0 | Direct |
1-17 of 17 transactions
About Vandebroek Sophie V.
Vandebroek Sophie V. (SEC CIK 0001442078) files insider reports with the SEC as Director of IDEXX LABORATORIES INC /DE (IDXX) and Director of REVVITY, INC. (RVTY).
Signal8 holds 8 ownership filings by Vandebroek Sophie V., all Form 4s, filed between Nov 29, 2024 and May 14, 2026. Those filings report 17 transactions, from Nov 27, 2024 to May 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Vandebroek Sophie V.'s filings is in WESTBROOK, ME.
Recent filings by Vandebroek Sophie V.
- May 12, 2026: Grants or awards of IDXX derivative securities (2 lines, Form 4, code A).
- May 7, 2026: Option exercise of IDXX shares (Form 4, code M).
- May 7, 2026: Grants or awards of RVTY shares (2 lines, Form 4, code A).
- Feb 17, 2026: Option exercise of IDXX shares (Form 4, code M).
- Feb 17, 2026: Open-market sales of IDXX shares (2 lines, Form 4, code S).
Other insiders filing for IDEXX LABORATORIES INC /DE (IDXX)
- Kingsley Lawrence D, Director
- Emerson Andrew, EVP, CFO and Treasurer
- HOOLEY JOSEPH L, Director
- FENNELL GEORGE, Executive Vice President
- SAMAD SAM, Director
- Peacock Karen, Director